HK1057204A1 - A thiazolidinedione derivative and its use as antidiabetic - Google Patents

A thiazolidinedione derivative and its use as antidiabetic

Info

Publication number
HK1057204A1
HK1057204A1 HK03107840A HK03107840A HK1057204A1 HK 1057204 A1 HK1057204 A1 HK 1057204A1 HK 03107840 A HK03107840 A HK 03107840A HK 03107840 A HK03107840 A HK 03107840A HK 1057204 A1 HK1057204 A1 HK 1057204A1
Authority
HK
Hong Kong
Prior art keywords
antidiabetic
compound
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
HK03107840A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1057204A1 publication Critical patent/HK1057204A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03107840A 2000-09-07 2003-10-30 A thiazolidinedione derivative and its use as antidiabetic HK1057204A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021978.2A GB0021978D0 (en) 2000-09-07 2000-09-07 Novel pharmaceutical
PCT/GB2001/003979 WO2002020517A1 (en) 2000-09-07 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
HK1057204A1 true HK1057204A1 (en) 2004-03-19

Family

ID=9899043

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03107840A HK1057204A1 (en) 2000-09-07 2003-10-30 A thiazolidinedione derivative and its use as antidiabetic

Country Status (15)

Country Link
US (1) US20040014791A1 (xx)
EP (1) EP1315721B1 (xx)
JP (1) JP2004508367A (xx)
KR (1) KR100769007B1 (xx)
CN (2) CN100415741C (xx)
AT (1) ATE343574T1 (xx)
AU (1) AU2001284274A1 (xx)
CY (1) CY1105903T1 (xx)
DE (1) DE60124119T2 (xx)
DK (1) DK1315721T3 (xx)
ES (1) ES2272528T3 (xx)
GB (1) GB0021978D0 (xx)
HK (1) HK1057204A1 (xx)
PT (1) PT1315721E (xx)
WO (1) WO2002020517A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
US20130158077A1 (en) 2011-12-19 2013-06-20 Ares Trading S.A. Pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9711683D0 (en) 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
ATE318138T1 (de) * 1998-06-30 2006-03-15 Takeda Pharmaceutical Pharmazeutisches mittel zur behandlung von diabetes

Also Published As

Publication number Publication date
KR100769007B1 (ko) 2007-10-22
KR20030031179A (ko) 2003-04-18
CN1471530A (zh) 2004-01-28
CY1105903T1 (el) 2011-02-02
DK1315721T3 (da) 2007-02-19
EP1315721A1 (en) 2003-06-04
US20040014791A1 (en) 2004-01-22
CN1814599A (zh) 2006-08-09
CN100415741C (zh) 2008-09-03
PT1315721E (pt) 2007-01-31
ES2272528T3 (es) 2007-05-01
DE60124119T2 (de) 2007-05-16
WO2002020517A1 (en) 2002-03-14
DE60124119D1 (de) 2006-12-07
GB0021978D0 (en) 2000-10-25
JP2004508367A (ja) 2004-03-18
EP1315721B1 (en) 2006-10-25
AU2001284274A1 (en) 2002-03-22
ATE343574T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
NZ515166A (en) Thiazolidinedione derivative and its use as antidiabetic
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
HK1057751A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
PT1349855E (pt) Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona
AP2002002673A0 (en) Thiazolidinedione salt for the treatment of diabetes mellitus.
NZ515164A (en) Thiazolidinedione derivative and its use as antidiabetic
AU2002343052A1 (en) Rosiglitazone edisylates and their use as antidiabetics
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
ECSP003434A (es) Nuevos compuestos

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100905